autologous activated lymphocyte
Cell therapyexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2009 (NCT00854854)
Timeline
2000s
- Jan 1, 2009
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- T-lymphocytesSupplementation
T-lymphocytes supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- autologous activated lymphocyte
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04187183 | N/A | Dec 4, 2019 | University of Bologna |
| NCT00854854 | Phase 1/Phase 2 (Phase 2) | Jan 1, 2009 | Binex, The Catholic Medical Center |
| NCT00854971 | Phase 1/Phase 2 (Phase 2) | Jan 1, 2009 | Binex, The Catholic Medical Center |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Binex | For profit | 2 | 2 | 1 | 2009 |
| The Catholic Medical Center | Academic/Hospital | 2 | 0 | 1 | 2009 |
| University of Bologna | Academic/Hospital | 1 | 1 | 1 | 2019 |
3 organizations
Page 1 / 1